PT  - JOURNAL ARTICLE
AU  - Stuart Maudsley
AU  - Bronwen Martin
AU  - Diane Gesty-Palmer
AU  - Huey Cheung
AU  - Calvin Johnson
AU  - Shamit Patel
AU  - Kevin G. Becker
AU  - William H. Wood
AU  - Yongqing Zhang
AU  - Elin Lehrmann
AU  - Louis M. Luttrell
TI  - Delineation of a Conserved Arrestin-Biased Signaling Repertoire In Vivo
AID  - 10.1124/mol.114.095224
DP  - 2015 Jan 30
TA  - Molecular Pharmacology
PG  - mol.114.095224
4099  - http://molpharm.aspetjournals.org/content/early/2015/01/30/mol.114.095224.short
4100  - http://molpharm.aspetjournals.org/content/early/2015/01/30/mol.114.095224.full
AB  - Biased G protein-coupled receptor agonists engender a restricted repertoire of downstream events from their cognate receptors, permitting them to produce mixed agonist-antagonist effects in vivo. While this opens the possibility of novel therapeutics, it complicates rational drug design, since the in vivo response to a biased agonist cannot be reliably predicted from its in vitro efficacy. We have employed novel informatic approaches to characterize the in vivo transcriptomic signature of the arrestin pathway-selective parathyroid hormone analog [D-Trp12, Tyr34]-bPTH(7-34) in six different murine tissues after chronic drug exposure. We find that [D-Trp12, Tyr34]-bPTH(7-34) elicits a distinctive arrestin-signaling focused transcriptomic response that is more coherently regulated across tissues than that of the pluripotent agonist, hPTH(1-34). This arrestin-focused network is closely associated with transcriptional control of cell growth and development. Our demonstration of a conserved arrestin-dependent transcriptomic signature suggests a framework within which the in vivo outcomes of arrestin-biased signaling may be generalized.